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In previous papers (1-3)  we showed that the Berkefeld filtrates of 
certain anaerobically produced autolysates of pneumococcus of Types 
I, II, or III cause in guinea pigs:  (a) necrosis of the skin when injected 
intracutaneously; (b) hemorrhagic edema of the lungs and death when 
injected intratracheally; (c) pneumonia associated with unrestrained 
multiplication of the organism in the lung when injected intratrache- 
ally in sublethal doses combined with small amounts of living organ- 
isms; and cause in mice death with kidney lesions, when injected intra- 
venously.  We also demonstrated that immunization of horses with 
these autolysates stimulates the production of sera of marked anti- 
toxic properties for the principles that cause, in guinea pigs necrosis of 
the skin and hemorrhagic edema of the lungs, and in mice kidney le- 
sions and death (4, 5).  Moreover, an antiautolysate serum, prepared 
by the immunization with the autolysate from one type of pneumo- 
coccus, neutralized the poisons affecting the skin and the lung pro- 
duced from each of the other 3 types, demonstrating that these autoly- 
sate  antitoxins  and presumably the  toxins  are not type specific  (1, 
4, 5). 
Despite much work toward the understanding of the pathogenesis 
of pneumococcus pneumonia, there are many obscure features of the 
disease that have never been explained satisfactorily.  If substances 
of the nature of the toxic autolysates could be demonstrated in vivo 
in animals having pneumococcus pneumonia, such  a  finding would 
help  explain  the phenomenon of lobar pneumonia in man.  It was 
with the object of determining whether poisons  similar to  those in 
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the toxic autolysates are produced in vivo,  that this work was under- 
taken. 
If the autolysate toxin is produced in vivo during the growth of the 
organism in the tissues, one would expect that the autolysate anti- 
toxin, through neutralization of the toxin, would at least delay death 
in animals injected with  the  pneumococcus.  This, however, is not 
the case.  We found that autolysate antitoxin injected even in large 
amounts is  unable  to  protect or prolong the life of guinea pigs or 
mice injected intramuscularly or intraperitoneally with a lethal dose 
of pneumococcus.  Moreover, Sabin  (6)  showed that our autolysate 
antitoxin, when used by itself or in combination with a so called sub- 
effective dose of specific antibacterial serum, had no apparent effect 
on the progress of pneumococcus infection in mice injected intraperi- 
toneally or in rabbits  injected intracutaneously with large doses of 
virulent pneumococci.  It  seems,  therefore,  evident from our  own 
work and from that of Sabin that toxic substances of the nature of 
those in  the toxic autolysates neutralizable by  the autolysate anti- 
toxin, are not produced in the animal body during generalized infec- 
tion with the pneumococcus. 
However, there appears to be another way of looking at this prob- 
lem.  In pneumococcus pneumonia in  man  and in  the guinea pig, 
pneumonia occurs with growth of the organisms in the lung, frequently 
without invasion of, or establishment of, the pneumococcus in other 
organs or tissues.  Is it possible, then, that the poisons in the autoly- 
sates,  especially  the  toxin  that  is  injurious  to  the  lungs,  enabling 
pneumococci to grow in them, are produced in vivo only in the lung? 
If this is the case, the autolysate antitoxin, through neutralization of 
these poisons in the lung, might have a curative effect in pneumonia 
in delaying or arresting the spread of pneumococcus infection.  In- 
directly this neutralizing action in the lung might prevent the occur- 
rence of a generalized infection, although it would have no direct effect 
on a pneumococcus  sepsis once established.  In an endeavor to answer 
this  question we have  produced pneumonia in  guinea pigs and at- 
tempted to protect them with autolysate antitoxin. 
Experimental  Methods 
Production of Pneumonia in Guinea Pigs.--Pneumonia was produced in guinea 
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1.  Intratracheal injection  of large  amounts  of living  virulent  pneumococci. 
(Pneumococci from 3 to 4 cc. of culture  in 0.2 cc. volume.) 
These pigs usually get moderately extensive pneumonia  lasting  about 2 days. 
In 2 instances a pig in this group died with an extensive pneumonia associated with 
unrestrained  growth of pneumococci in the lung, similar to the pneumonia  caused 
by the intratracheal injection  of a mixture  of small amounts of autolysate toxin 
and living  pneumococci.  All animals  in this group died  with a  pneumococcus 
sepsis 2 to 5 days after injection. 
2.  Intratracheal injection of large amounts of living virulent pneumococci into 
guinea pigs prepared either immediately previously or 18 hours previously by intra- 
peritoneal injection  of small  amounts of homologous antibacterial  (horse)  sera 
(7, 8).  (Pneumococci from 4 to 6 cc. of culture in 0.2 cc. to 0.25 cc. volume.) 1 
These pigs usually develop extensive pneumonia and die 1 to 4 days after injec- 
tion with sepsis.  (The lung involvement is greater than that produced by method 
1.)  Occasionally  the  guinea  pigs  of  this  group  develop  extensive  pneumonia 
associated with unrestrained  growth of the organism in the lung.  Very rarely an 
animal of this group survives. 
3.  Intratracheal  injection  of a  small  amount of living  pneumococcus  organ- 
isms combined  with sublethal  doses of staphylococcus  toxin. 
These pigs usually develop extensive pneumonia in 1 to 4 days after injection 
and sepsis.  Frequently the pigs in this group develop extensive pneumonia  asso- 
ciated with unrestrained growth of the organisms in the lung. 
Pneumococcus Cultures Used.--A Pneumococcus  Type I  and a  Pneumococcus 
Type II strain were used for inoculation  of the guinea pigs in this work in all 3 
groups of guinea pigs.  Both strains were obtained from the blood of patients with 
lobar pneumonia at the Presbyterian Hospital.  The virulence of the strains  was 
kept up by passage through guinea pigs.  The organisms were grown under vase- 
line seal on a  double  strength veal infusion  broth containing  4 per cent Witte 
peptone.  After 12 to 14 hours growth,  the pneumococcus  culture was iced and 
~ntrifuged and the organisms taken up in the required amount of the supernatant 
broth.  The pneumococcus suspension was then adjusted to a pH of 7 to 7.2 and 
kept in ice water during the experiment. 
Staphylococcus Toxin.--The staphylococcus  toxin  used  in this work was pre- 
pared from a hemolytic Staphylococcus aureus strain recovered from the blood of a 
case of staphylococcus septicemia in October, 1934.  When injected intratracheally 
in guinea pigs in 0.1 cc. amounts, it produces hemorrhagic edema of the lungs and 
death. 
Sera Used.--Pneumococcus  autolysate antitoxin: The autolysate antitoxin used 
in these experiments  was  a concentrated and refined serum obtained from horses 
immunized ~ to the sterile  toxic autolysate filtrates  from Pneumococcus Types I, 
II,  and  III.  This  antitoxin  contains  no  specific antibacterial  substances  for 
x  In this work we shall speak of these partly immune guinea pigs as sensitized. 
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Pneumococcus Types I, II, or III.  At present it has a titre of 4500 guinea pig 
units and 7800 mouse units per cc. 
Specific antibacterial  sera: Antibacterial serum Type I--New York Board of 
Health.  Refined--containing 2500 units per cc.  Antibacterial serum Type II-- 
New York Board of Health.  Refined--containing 3000 units per cc. 
Normal horse serum: Inactivated. 
Effect of Pneumococcus Autolysate Antitoxin on the Pneumonia 
Caused by the Intratracheal  Injection of Large 
Amounts of Pneumococcus 
In Table I is presented a protocol of an experiment in which autol- 
ysate antitoxin  or  normal horse  serum was  given  intraperitoneally 
immediately after the intratracheal inoculation of pneumococcus sus- 
pension,  and  demonstrates clearly the protective effect of the anti- 
toxin.  There is a  discrepancy in this experiment in that guinea pig 
10 that received antitoxin died in  1 day.  In a large number of ani- 
mals inoculated intratracheally with large amounts of living pneumo- 
cocci, we have found that there is a  small percentage of guinea pigs 
(approximately 10 per cent) that appear to be especially susceptible to 
the organisms and we believe that a much greater susceptibility than 
normal explains the early death of this guinea pig.  An instance of 
this in another experiment was the death of a  guinea pig in 2 hours 
after  the  intratracheal  inoculation  of  pneumococcus.  This  guinea 
pig showed at autopsy lungs already large, with patchy hemorrhagic 
pneumonia throughout.  4 guinea pigs inoculated with the same quan- 
tity of organisms as this latter guinea pig survived for 2 or 3  days. 
In respect to guinea pig 10, Table I, it is of interest to note that the 
culture from its heart blood was negative, whereas in all the 8  con- 
trol guinea pigs,  positive heart blood cultures were obtained.  This 
occurred in another experiment in which 1 of 9 guinea pigs inoculated 
with antitoxin died and it had a  negative heart culture at autopsy, 
while all the controls died having positive heart cultures. 
Several experiments similar to the experiment, Table I, with minor 
variations have been carried out, always with substantially the same 
results.  We found that one-half the amount of antitoxin injected in 
the experiment, Table I, viz.,  1 cc. of 1-2 dilution, was sufficient to 
save the animals.  As shown in experiment, Table I,  and confirmed 
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Effect of Pneumococcus Autolysate Antitoxin on the Pneumonia Caused by the 
IntratrackeaI Injection in Guinea Pigs of Large 
Amounts of Pneumococci 
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Pneumococcus  I  Suspension.--The  organisms  from  3  cc.  of  culture  were 
inoculated into each guinea pig.  The normal horse serum or antitoxin was inocu- 
lated intraperitoneally into each pig immediately after the intratracheal inocula- 
tion of organisms.  One animal from each group  (no serum, horse serum, anti- 
toxin)  was inoculated,  then  a  second animal from each group and  so  forth,  so 
that  any  change  that  might  possibly  occur  in  the  suspension  of pneumococci 
during  the  time taken  to  inoculate would be  distributed  equally among the  3 
groups of guinea pigs.  This procedure was carried out in all our other experi- 
ments. 
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has no beneficial effect against the intratracheal inoculation of pneu- 
mococci.  There appears to be no doubt, therefore, that the autoly- 
sate  antitoxin under the  conditions of  these  experiments saves  the 
great majority of animals injected intratracheally with large doses of 
living pneumococcus. 
Effect of Autolysate  Antitoxin on the Pneumonia Caused in 
Specifically Sensitized Guinea Pigs by the Intratracheal 
Inoculation  of Large Doses of Living Pneumococci 
In Table II is presented a protocol of an experiment in which autoly- 
sate antitoxin or normal horse serum was given intraperitoneally 1 day 
and 2 hours before the intratracheal inoculation of pneumococci into 
sensitized guinea pigs.  It is seen that only one of the 6 control guinea 
pigs survived whereas all  the  antitoxin treated guinea pigs survived, 
demonstrating the  efficacy  of  the  antitoxin  against  the  pneumonia 
under the conditions of this  experiment. 
This type of experiment (Table II) has been repeated several times 
with variations as  to  the  time at  which  the antitoxin  and  specific 
antibacterial serum were given in respect to the intratracheal inocula- 
tion of organisms, always with essentially the same results.  In one 
experiment the autolysate antitoxin was given intravenously 18 hours 
after the injection of pneumococcus into sensitized guinea pigs at a 
time when the guinea pigs had symptoms of well advanced pneumonia, 
and  the  antitoxin  treated guinea pigs lived much longer than  the 
control pigs, or survived. 
These experiments, therefore, indicate that the autolysate antitoxin 
in most instances saves guinea pigs from an almost surely fatal pneu- 
monia caused by the injection of large doses of pneumococcus into 
specifically sensitized guinea pigs. 
Effect of Autolysate Antitoxin on the Pneumonia Caused by the 
Intratracheal Injection of Mixtures of Staphflococcus 
Toxin and Pneumococcus Culture 
Although, as has been pointed out previously, pneumococcus autoly- 
sate antitoxin has no effect on the progress of a  systemic infection 
with the pneumococcus, from the foregoing experiments it is evident 
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guinea  pigs  from  an  almost  surely  fatal  pneumonia.  This  would 
seem to favor the conjecture that the toxin or toxins in pneumococcus 
pneumonia are  elaborated  in  the  lung.  But  there  appears  to  be 
another possible explanation of these results.  The suspension of pneu- 
mococci injected to  produce pneumonia contained per  cubic centi- 
meter approximately only 1/30 of the organisms present in the sus- 
pension from which the autolysate toxin was produced.  However, it 
seems conceivable that in the lung and bronchi enough of the intro- 
duced pneumococci could have been autolyzed so as to produce suf- 
ficient toxin to cause a primary injury, thus enabling the pneumococci 
to become established in the lung. 
If this were the case, the beneficial effect of the autolysate antitoxin 
could be ascribed to  the neutralization of the poison or poisons as- 
sumed to have been produced from the in vivo autolysis of the inocu- 
lated  pneumococci rather  than  to  the neutralization of  the poisons 
produced  during  the  growth  and  autolysis  of  the freshly  growing 
pneumococci in the lung.  In such case the antitoxin might have pre- 
vented the start of the infection and saved the animal.  From this 
reasoning, therefore, it appears that the foregoing experiments furnish 
no proof of the production of the autolysate poison in vivo from or- 
ganisms growing in the lung. 
We  have  already  shown  that  autolysate  antitoxin  prevents  the 
development of pneumonia and death otherwise induced by the intra- 
tracheal injection of small doses of living pneumococci combined with 
sublethal  doses  of pneumococcus autolysate  poison  (5).  But  here 
again the beneficial effect of the antitoxin might be ascribed to the 
neutralization of the inoculated toxin and not to the neutralization of 
the autolysate toxin possibly elaborated in the lung by the growth of 
the organisms there. 
It seemed to us that one way of answering this question was to 
infect animals intratracheally with doses of pneumococci too small 
to cause pneumonia by themselves, combined with a  substance toxic 
for the lung but nonspecific for the pneumococcus, for the purpose of 
enabling the organisms to become established in the lung and thus 
cause pneumonia.  If antitoxin were found effective in this kind of 
pneumonia, it would be logical to infer that the antitoxin had neu- 
tralized poisons produced in some way by the growing and autolyzing JULIA T.  WELD AND  HELENA  GILDER  961 
organisms  and  that  therefore  the  autolysate  poison  or  poisons  are 
presumably produced  in  the lung.  With  this idea in mind,  we pro- 
duced  pneumonia  in  guinea  pigs  by  injecting  them  intratracheally 
with sublethal doses of staphylococcus toxin, which is toxic for lungs 
TABLE III 
Effect of Pneumococcus Autolysate  Antitoxin on the Pneumonia Caused in Guinea 
Pigs by the Intratracheal Injection of Mixtures of Pneumococcus 
Culture and Staphylococcus Toxin 
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The  pneumococcus antitoxin,  diluted  1-2,  was  injected  intraperitoneally  4 
hours  before  the  intratracheal  inoculation.  0.3  cc.  of  Pneumococcus  Type  I 
(14 hours growth) was mixed with 0.1 cc. of staphylococcus toxin and 0.2 cc. of 
the mixture inoculated intratracheally into each guinea pig. 
when  injected  intratracheally,  mixed  with  small  doses  of  living 
pneumococci and were able to save most of these animals with injec- 
tions  of  autolysate  antitoxin  previously  administered.  Table  III 
gives the  results of one of the  experiments of this kind. 
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substantially  the  same  results  demonstrates  that  pneumococcus 
autolysate  antitoxin  has  a  definitely beneficial effect on the pneu- 
monia caused by the injection of mixtures of staphylococcus toxin and 
the pneumococcus. 
Regarding further control experiments, which are not included in 
the tables,  it has been found:  (a)  that the pneumococcus antitoxin 
has  no more detoxifying effect on  the  staphylococcus toxin  (when 
mixed in vitro and inoculated into guinea pigs) than has normal horse 
serum, and that,  therefore, the results of the above experiments are 
not  caused  by  a  nonspecific neutralization  or  destruction  of  the 
staphylococcus toxin; and  (b)  that normal horse serum given intra- 
peritoneally has no effect in prolonging the life or saving the guinea 
pigs inoculated with pneumococcus culture  +  staphylococcus toxin 
mixtures. 
These  experiments  with  staphylococcus  toxin  show  clearly  that 
the antitoxin neutralizes the poison or poisons produced in the lung 
by  the invading and growing organism and  that presumably these 
poisons are the same as those present in the toxic autolysate. 
DISCUSSION 
The  experiments  in  this  paper  demonstrate  that  pneumococcus 
autolysate  antitoxin  under  certain  conditions is  efficacious against 
pneurnococcus pneumonia in guinea pigs.  The plausible explanation 
of these results is that the antitoxin neutralizes poisons manufactured 
by  the growing and autolyzing pneumococci in  the lung, thus pre- 
venting the spread of the infection by preventing damage to the tis- 
sues.  Since the antitoxin is produced by the immunization of horses 
with the toxic autolysates and since it neutralizes in vitro all the so 
far determined poisons contained in the autolysates, and in vivo the 
toxin that enables pneumococci to grow in the lung,  3 it is reasonable 
to believe that the poisons neutralized by the antitoxin in the lung 
are similar to those present in the toxic autolysates. 
Whether all the toxic effects of the autolysates are important in 
the production of pneumonia is impossible to say.  The toxins that 
enable pneumococci to grow in the lung would appear to be the most 
important toxins in this respect.  That the dermotoxic substance in 
the autolysates has little if any importance in pneumococcus infec- 
3  Weld, J. T., unpublished experiments. JULIA T.  WELD AND HELENA GILDER  963 
tions appears probable from the work of Sabin.  He showed that the 
autolysate antitoxin had no beneficial effect against the Goodner (9) 
so called intradermal pneumonia in rabbits caused by the intradermal 
infection by virulent pneumococci.  Even large doses of autolysate 
antitoxin did not appear to delay or arrest the development of the 
local lesion nor to modify the fully developed lesion. 
If it is  confirmed that the pneumococcus autolysate toxin is pro- 
duced only in the lung in pneumonia, it would seem that in pneumococ- 
cus infections one must distinguish between poisons that are produced 
in the lung and those that are produced when the organism is growing 
in other tissues generally.  The dermotoxic and fever producing toxins 
of Coca (10) may possibly belong in the latter class of poisons. 
CONCLUSIONS 
1.  In  rabbits,  guinea  pigs,  and  mice  pneumococcus  autolysate 
antitoxin has no effect against generalized infection by the pneumococ- 
cus. 
2.  In a large proportion of cases of pneumonia and sepsis caused by 
the intratracheal inoculation of large amounts of living pneumococci 
in  normal or  sensitized guinea pigs,  autolysate antitoxin  saves  the 
animal. 
3.  The  autolysate  antitoxin  is  protective in  most  cases of pneu- 
monia  and  sepsis  caused by  the  intratracheal  inoculation  of  small 
amounts  of  living  pneumococci  combined  with  sublethal  doses  of 
staphylococcus toxin. 
4.  These experiments indicate that in pneumococcus pneumonia of 
guinea pigs the autolysate toxin or toxins are elaborated only in the 
lungs. 
BIBLIOGRAPHY 
1. Parker, J. T., J. Exp. Med., 1928, 47, 531. 
2.  Parker, J. T., and Pappenheimer, A. M., 3". Exp. Med., 1928, 48  s 695. 
3. Weld, J. T., and Gunther, A., J. Exp. Med., 1935, 62, 119. 
4. Parker, J. T., and McCoy, M. Van S., ]. Exp. Med., 1929, 50, 103. 
5.  Parker, J. T., J. Exp. Med., 1929, 50, 161. 
6. Sabin, A. B., Proc. Soc. Exp. Biol. and Med., 1930, 28, 457. 
7. Wadsworth, A., Am. 3.. Med. Sc.,  1904, 127, 851. 
8. Branch, A., and StiUman, E., 3.. Exp. Med., 1924, 40, 743. 
9.  Goodner, K., 3.. Exp. Med.,  1928, 68, 2. 
10.  Coca,  A. F., 3". Imm. unol., 1936, 80, 1. 